
Everest Medicines Investor Relations Material
Latest events

H2 2024
Everest Medicines
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Everest Medicines Limited
Access all reports
Everest Medicines Limited is a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative medicines. The company specializes in therapies for infectious diseases, autoimmune disorders, and oncology. It partners with global biotechnology firms to bring advanced treatments to markets in China and other Asian regions. The company is headquartered in Shanghai, China, and its shares are listed on the Hong Kong Stock Exchange (HKEX).
Key slides for Everest Medicines Limited


Study Update
Everest Medicines Limited


H2 2024
Everest Medicines Limited
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
1952
Country
🇭🇰 Hong Kong